Literature DB >> 21560483

Insight into the mechanisms regulating immune homeostasis in health and disease.

Stitaya Sirisinha1.   

Abstract

Innate and adaptive immune systems consist of cells and molecules that work together in concert to fight against microbial infection and maintain homeostasis. Hosts encounter microbes / exogenous pathogen-associated molecular patterns (PAMPs) and endogenous damage-associated molecular patterns (DAMPs) all the time and they must have proper mechanisms to counteract the danger such that appropriate responses (e.g., degree of inflammation and types of mediators induced) can be mounted in different scenarios. Increasing numbers of endogenous danger signals of host origin are being identified including, for example, uric acid and cholesterol crystals, high mobility group box1 (HMGB1) protein, oxidized LDL, vesicans, heat shock proteins (HSPs) and self DNA. Many of these endogenous ligands have been shown to be associated with inflammation-related diseases like atherosclerosis, gout and type 2 diabetes. Several DAMPs appear to have the ability to interact with more than one receptor. We are now beginning to understand how the immune system can distinguish infection from endogenous ligands elaborated following cellular insults and tissue damage. Appropriate responses to maintain the homeostatic state in health and disease depend largely on the recognition and response to these stimuli by germline encoded pattern-recognition receptors (PRRs) present on both immune and non-immune cells. These receptors are, for example, Toll-like receptors (TLRs), C-type lectin receptors (CLRs) and cytosolic receptors (e.g., RLRs, NLRs and some intracellular DNA sensors). Atypical PRR "danger" receptors, like the receptor for advanced glycation end products (RAGE) and their ligands have been identified. A proper response to maintain homeostasis relies on specific negative regulators and regulatory pathways to dampen its response to tissue injury while maintaining the capacity to eliminate infection and induce proper tissue repair. Moreover, some PRRs (e.g., TLR2,TLR4 and NLRP3) and atypical PRRs can recognize both PAMPs and DAMPs, either as single entities or after forming complexes (e.g., immune complexes, or DNA- HMGB1 and DNA-LL37 complexes), so there must be a mechanism to selectively depress or alleviate the inflammatory response to DAMPs, while leaving that of PAMPs intact. Excessive inflammatory responses can induce considerable tissue damage and can be highly detrimental to the host. For example, CD24 reacting with HMGB1 and HSPs has been implicated to function as negative regulator for RAGE. In this review, I will briefly overview the information on various host and microbial components and bring together the information to synthesize a model to explain how homeostasis can be maintained in states of health and disease. Understanding the molecular mechanisms by which the immune system functions under different scenarios will provide us with ways and means to design appropriate approaches, for example, to prevent or treat autoimmune and inflammatory diseases or the ability to design new drugs or formulate safe chemicals for vaccine adjuvants.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21560483

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  19 in total

1.  Brain innate immunity regulates hypothalamic arcuate neuronal activity and feeding behavior.

Authors:  Wagner L Reis; Chun-Xia Yi; Yuanqing Gao; Mathias H Tschöp; Javier E Stern
Journal:  Endocrinology       Date:  2015-02-03       Impact factor: 4.736

2.  Chitinase 3-like-1 promotes Streptococcus pneumoniae killing and augments host tolerance to lung antibacterial responses.

Authors:  Charles S Dela Cruz; Wei Liu; Chuan Hua He; Adam Jacoby; Alex Gornitzky; Bing Ma; Richard Flavell; Chun Geun Lee; Jack A Elias
Journal:  Cell Host Microbe       Date:  2012-07-19       Impact factor: 21.023

Review 3.  Neuroimmunomodulation in depression: a review of inflammatory cytokines involved in this process.

Authors:  Helena M Abelaira; Gislaine Z Réus; Fabricia Petronilho; Tatiana Barichello; João Quevedo
Journal:  Neurochem Res       Date:  2014-07-05       Impact factor: 3.996

4.  Sterile inflammation in acetaminophen-induced liver injury is mediated by Cot/tpl2.

Authors:  Carlos Sanz-Garcia; Gemma Ferrer-Mayorga; Águeda González-Rodríguez; Angela M Valverde; Antonio Martín-Duce; Juan P Velasco-Martín; Javier Regadera; Margarita Fernández; Susana Alemany
Journal:  J Biol Chem       Date:  2013-04-09       Impact factor: 5.157

Review 5.  Electroimmunology and cardiac arrhythmia.

Authors:  Jana Grune; Masahiro Yamazoe; Matthias Nahrendorf
Journal:  Nat Rev Cardiol       Date:  2021-03-02       Impact factor: 32.419

6.  Spontaneous periodontitis development in diabetic rats involves an unrestricted expression of inflammatory cytokines and tissue destructive factors in the absence of major changes in commensal oral microbiota.

Authors:  Marcela Claudino; Gabriela Gennaro; Tania Mary Cestari; César Tadeu Spadella; Gustavo Pompermaier Garlet; Gerson Francisco Assis
Journal:  Exp Diabetes Res       Date:  2012-05-07

7.  Damage-associated Molecular Patterns in Clinical and Animal Models of Uveitis.

Authors:  Henry J Kaplan; Deming Sun; Hui Shao
Journal:  Ocul Immunol Inflamm       Date:  2021-09-03       Impact factor: 3.728

8.  HMGB1 release triggered by the interaction of live retinal cells and uveitogenic T cells is Fas/FasL activation-dependent.

Authors:  Guomin Jiang; Yunsong Wang; Juan Yun; Amir Reza Hajrasouliha; Yuan Zhao; Deming Sun; Henry J Kaplan; Hui Shao
Journal:  J Neuroinflammation       Date:  2015-09-22       Impact factor: 8.322

Review 9.  Arenavirus evasion of host anti-viral responses.

Authors:  Melissa Hayes; Maria Salvato
Journal:  Viruses       Date:  2012-10-17       Impact factor: 5.048

Review 10.  Roles of Commensal Microbiota in Pancreas Homeostasis and Pancreatic Pathologies.

Authors:  Camila Leal-Lopes; Fernando J Velloso; Julia C Campopiano; Mari C Sogayar; Ricardo G Correa
Journal:  J Diabetes Res       Date:  2015-08-06       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.